I agree that this site is using cookies. You can find further informations here.
X
Juliachs, Mercè
14  results:
Search for persons X
?
1

Circulating SOD2 Is a Candidate Response Biomarker for Neoa..:

Juliachs, Mercè ; Pujals, Mireia ; Bellio, Chiara...
Cancers.  14 (2022)  16 - p. 3858 , 2022
Link: https://doi.org/10.3390/..
 
?
2

Effectivity of pazopanib treatment in orthotopic models of ..:

Juliachs, Mercè ; Vidal, August ; del Muro, Xavier Garcia...
BMC Cancer.  13 (2013)  1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
3

Circulating SOD2 Is a Candidate Response Biomarker for Neoa..:

Juliachs, Mercè ; Pujals-Pruneda, Mireia ; Meo-Evoli, Nathalie...
Cancers;14(16).  , 2022
Link: https://hdl.handle.net/1..
 
?
4

Circulating SOD2 Is a Candidate Response Biomarker for Neoa..:

Juliachs, Mercè ; Pujals, Mireia ; Bellio, Chiara...
Reproducció del document publicat a: https://doi.org/10.3390/cancers14163858.  , 2022
Link: http://hdl.handle.net/24..
 
?
5

Circulating SOD2 Is a Candidate Response Biomarker for Neoa..:

Juliachs, Mercè ; Pujals, Mireia ; Bellio, Chiara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405919/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Effectivity of pazopanib treatment in orthotopic models of ..:

Juliachs, Mercè ; Vidal, August ; del Muro, Xavier...
http://www.biomedcentral.com/1471-2407/13/382.  , 2013
Link: http://www.biomedcentral..
 
?
7

Circulating SOD2 Is a Candidate Response Biomarker for Neoa..:

Mercè Juliachs ; Mireia Pujals ; Chiara Bellio...
https://www.mdpi.com/2072-6694/14/16/3858.  , 2022
Link: https://doi.org/10.3390/..
 
?
8

Circulating SOD2 Is a Candidate Response Biomarker for Neoa..:

Mercè Juliachs ; Mireia Pujals ; Chiara Bellio...
Cancer Biomarkers.  , 2022
Link: https://doi.org/10.3390/..
 
?
9

The PDGFRβ-AKT pathway contributes to CDDP-acquired resista..:

Juliachs Milà, Mercè ; Muñoz, C ; Moutinho, Cátia...
Versió postprint del document publicat a: https://doi.org/10.1158/1078-0432.CCR-13-1131.  , 2014
Link: http://hdl.handle.net/24..
 
?
10

Teràpia dirigida a receptors ErbBs i teràpia antiangiogènic..:

Juliachs Milà, Mercè
B 13663-2014.  , 2013
Link: http://hdl.handle.net/10..
 
?
11

Teràpia dirigida a receptors ErbBs i teràpia antiangiogènic..:

Juliachs Milà, Mercè
Tesis Doctorals - Departament - Ciències Fisiològiques II.  , 2013
Link: http://hdl.handle.net/24..
 
?
12

ErbBs inhibition by lapatinib blocks tumor growth in an ort..:

Juliachs Milà, Mercè ; Castillo-Ávila, Wilmar ; Vidal-Bel, August...
Versió postprint del document publicat a: https://doi.org/10.1002/ijc.28009.  , 2013
Link: http://hdl.handle.net/24..
 
?
13

Effectivity of pazopanib treatment in orthotopic models of ..:

Juliachs Milà, Mercè ; Vidal-Bel, August ; García del Muro Solans, Xavier...
Reproducció del document publicat a: http://dx.doi.org/10.1186/1471-2407-13-382.  , 2013
Link: http://hdl.handle.net/24..
 
?
14

Complements alimentaris: control oficial:

Juliachs-Petit, Elena ; Ardèvol-Ferrer, Elisabeth ; Armengol-Gili, Sebastià...
Gestió del Coneixement;2018-2019.  , 2019
Link: https://hdl.handle.net/1..
 
1-14